Stockreport

VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share  (AMRN) 
Last amarin corporation plc - american depositary shares, each representing one ordinary share earnings: 4/30 05:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.amarincorp.com/investors
PDF Study quantified coronary plaque changes in patients administered 4 g/day of VASCEPA® (icosapent ethyl) on top of statin therapy Effect on coronary plaque stabilizati [Read more]